NASSCOM’s feedback on MoHFW's ‘Draft notification to notify all the medical devices under sub-section (b) of section 3 of the Drugs and Cosmetics Act, 1940’

Terms of use

Terms of Use

The use of this site and the content contained therein is governed by the Terms of Use. When you use this site you acknowledge that you have read the Terms of Use and that you accept and will be bound by the terms hereof and such terms as may be modified from time to time.

All text, graphics, audio, design and other works on the site are the copyrighted works of nasscom unless otherwise indicated. All rights reserved.
Content on the site is for personal use only and may be downloaded provided the material is kept intact and there is no violation of the copyrights, trademarks, and other proprietary rights. Any alteration of the material or use of the material contained in the site for any other purpose is a violation of the copyright of nasscom and / or its affiliates or associates or of its third-party information providers. This material cannot be copied, reproduced, republished, uploaded, posted, transmitted or distributed in any way for non-personal use without obtaining the prior permission from nasscom.
The nasscom Members login is for the reference of only registered nasscom Member Companies.
nasscom reserves the right to modify the terms of use of any service without any liability. nasscom reserves the right to take all measures necessary to prevent access to any service or termination of service if the terms of use are not complied with or are contravened or there is any violation of copyright, trademark or other proprietary right.
From time to time nasscom may supplement these terms of use with additional terms pertaining to specific content (additional terms). Such additional terms are hereby incorporated by reference into these Terms of Use.

Disclaimer

The Company information provided on the nasscom web site is as per data collected by companies. nasscom is not liable on the authenticity of such data.
nasscom has exercised due diligence in checking the correctness and authenticity of the information contained in the site, but nasscom or any of its affiliates or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this site. The information from or through this site is provided "as is" and all warranties express or implied of any kind, regarding any matter pertaining to any service or channel, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement are disclaimed. nasscom and its affiliates and associates shall not be liable, at any time, for any failure of performance, error, omission, interruption, deletion, defect, delay in operation or transmission, computer virus, communications line failure, theft or destruction or unauthorised access to, alteration of, or use of information contained on the site. No representations, warranties or guarantees whatsoever are made as to the accuracy, adequacy, reliability, completeness, suitability or applicability of the information to a particular situation.
nasscom or its affiliates or associates or its employees do not provide any judgments or warranty in respect of the authenticity or correctness of the content of other services or sites to which links are provided. A link to another service or site is not an endorsement of any products or services on such site or the site.
The content provided is for information purposes alone and does not substitute for specific advice whether investment, legal, taxation or otherwise. nasscom disclaims all liability for damages caused by use of content on the site.
All responsibility and liability for any damages caused by downloading of any data is disclaimed.
nasscom reserves the right to modify, suspend / cancel, or discontinue any or all sections, or service at any time without notice.

For any grievances under the Information Technology Act 2000, please get in touch with Grievance Officer, Mr. Anirban Mandal at data-query@nasscom.in.

New

See all

No notification found.

NASSCOM’s feedback on MoHFW's ‘Draft notification to notify all the medical devices under sub-section (b) of section 3 of the Drugs and Cosmetics Act, 1940’

Komal Gupta

@Komal

November 19, 2019

Public Policy

726

As the representative of the information technology industry, we thank the Ministry of Health and Family Welfare (MoHFW) for this opportunity to present our views and suggestions on the Draft notification to notify all the medical devices under sub-section (b) of section 3 of the Drugs and Cosmetics Act, 1940 to regulate them as per the provisions of the said Act and Medical Devices Rules, 2017 framed thereunder (draft notification).

We appreciate the intent of MoHFW to adopt a new definition of medical devices, which would help align the Indian regulatory regime with the global practices.

NASSCOM organized a policy roundtable on the issue of regulation of medical devices and received feedback from the industry. Based on inputs from our members and other stakeholders, we have prepared our response, which reviews the various aspects of the draft notification along with our comments and suggestions.

NASSCOM Recommendations

To avoid ambiguity on the standards that are to be met for manufacturing/importing a medical device, the MoHFW should notify the standards for all medical devices after due consultation with the industry. NASSCOM would be happy to organize industry consultations in this regard.
The standard prescribed should be harmonised with the global practices to facilitate simpler requirements for quality products that are imported.
Under the US regulation, a manufacturer of a wearable (which tracks certain basic health parameters) who intends to sell it as a medical device can choose to be under the medical device regulation and sell the product after due approval from the regulator. On the contrary, the manufacturer can choose to sell a wearable as a consumer product if there is no intention to sell the product as a medical product. This approach should be adopted in India and the MoHFW should issue a clarification to establish this approach.
The MoHFW should issue a clarification to establish that standalone software is not covered under the proposed definition of medical devices.
Though we welcome the move to regulate medical devices by bringing them under the definition of the drug, going forward, the MoHFW should consider enacting a separate law to regulate medical devices.

The detailed submission has been attached with this blog. Please download the attachment.

In case of any further clarification or suggestion, please write to komal@nasscom.in and jayakumar@nasscom.in

NASSCOM policy healthcare roundtable health medical devices drugs MoHFW draft notification

Disclaimer

That the contents of third-party articles/blogs published here on the website, and the interpretation of all information in the article/blogs such as data, maps, numbers, opinions etc. displayed in the article/blogs and views or the opinions expressed within the content are solely of the author's; and do not reflect the opinions and beliefs of NASSCOM or its affiliates in any manner. NASSCOM does not take any liability w.r.t. content in any manner and will not be liable in any manner whatsoever for any kind of liability arising out of any act, error or omission. The contents of third-party article/blogs published, are provided solely as convenience; and the presence of these articles/blogs should not, under any circumstances, be considered as an endorsement of the contents by NASSCOM in any manner; and if you chose to access these articles/blogs , you do so at your own risk.

Download Attachment

Komal Gupta

Policy Analyst

Policy Professional| Former Tech and Business Journalist|

Call for Inputs: SEBI's consul...

Swapnil